Artificial Intelligence (AI) in Remote Patient Monitoring Market Size, Share, and Industry Analysis By Type (Hardware, Software, and Services), By Technology (Machine Learning, Natural Language Processing, Speech Recognition, and Others), By Application (Oncology, Diabetes, Cardiovascular Diseases, and Others), By End-user (Hospitals & ASCs, Home-care Settings, and Others), and Regional Forecast, 2026-2034

The global artificial intelligence in remote patient monitoring market size was valued at USD 2.06 billion in 2025. The market is projected to grow from USD 2.1 billion in 2026 to USD 2.47 billion by 2034, exhibiting a CAGR of 2.02% during the forecast period.

Artificial Intelligence (AI) in remote patient monitoring is used to enhance patient care, increase efficiency and enable early detection of diseases. Remote patient monitoring helps monitor a patient’s health condition remotely, which helps reduce the need for frequent in-person visits. The use of artificial intelligence (AI) further enhances remote patient monitoring by analyzing large volumes of patient information to identify trends, anomalies, and potential issues.

The use of Artificial intelligence (AI) in remote patient monitoring also helps in the detection of health deterioration. The technology enables continuous data collection, analysis, and early identification of potential health issues, especially for individuals with chronic conditions, such as diabetes, cancer, cardiovascular disorders, and others, or those recovering from acute illnesses.

Therefore, the increasing prevalence of the diseases mentioned above has been fueling the demand for the incorporation of artificial intelligence (AI), which enables remote patient monitoring.

• For instance, as per a study published by the National Center for Biotechnology Information (NCBI) in January 2022, the global diabetes prevalence in people with 20-79 years age in 2021 was estimated to be 10.5%, which is 536.6 million people and is expected to rise by 12.2% by 2045.

Moreover, the increasing launch of new technologies with artificial intelligence (AI) for remote patient monitoring fuels the industry growth. The market expansion is further driven by the rising focus of key players in mergers, acquisitions, and partnerships to develop solutions with advanced technologies to enhance the process of remote patient monitoring.

The global artificial intelligence (AI) in the remote patient monitoring market experienced an increase in its growth during the COVID-19 outbreak in 2020 as people adopted the use of remote patient monitoring solutions. During the pandemic, people were unable to visit hospitals and clinics due to lockdown restrictions, which increased the demand for remote patient monitoring. Moreover, the market growth was also due to the increasing use of remote patient monitoring owing to its advantages, such as reduced healthcare costs, reduced risk of infection, early detection of diseases, better health outcomes for people staying in rural areas, and others.

Furthermore, the market grew at a significant growth rate in 2021 and 2022 as artificial intelligence (AI) in remote patient monitoring was used extensively by many healthcare providers for monitoring the symptoms of COVID-19 patients to reduce the risk of health deterioration.

For instance, in 2022, a research study published by the European Respiratory Journal, stated that remote patient monitoring supported with artificial intelligence (AI) was used widely as a tool to reduce the hospital stay of COVID-19 patients by five days.

Key Insights

The report covers the following key insights:

• Prevalence of Key Chronic Diseases - by Key Countries/Sub-region, 2022/2023
• Technological Advancements in Remote Patient Monitoring Solutions
• Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
• Impact of COVID-19 on the Artificial Intelligence (AI) in Remote Patient Monitoring Market

Segmentation

Analysis by Type

On the basis of type, the hardware segment accounted for a significant market share in 2023. The growth of the segment is attributed to the increasing focus of key players on getting approval for devices from key regulatory authorities.

• For instance, in May 2021, Biobeat, a company that develops remote patient monitoring and data collection tools, announced that its full AI-powered wearable remote patient monitoring platform  received a full CE Mark.

The software segment is expected to grow at a substantial CAGR during the forecast period. The segment growth is attributed to the increasing demand for software used for remote patient monitoring.

• For instance, in January 2022, Coviu, a telehealth company, partnered with Propell Health, a distributor of iHealth medical devices, to launch an integrated telehealth and remote patient monitoring (RPM) software solution for the management of COVID-19 patients.

Regional Analysis

North America is projected to account for a significant share of the global artificial intelligence (AI) in the remote patient monitoring market in 2023. The regional market growth is attributed to the strong focus of key market players on launching new products for remote patient monitoring.

• For instance, in March 2023, Implicity, a developer of a remote monitoring platform, launched a new SMART on the FHIR application to improve interoperability and workflow efficiencies for remote patient monitoring providers.

Furthermore, the Europe market is expected to grow at a significant CAGR during the forecast period. The rising prevalence of cardiovascular diseases and the adoption of strategies such as collaborations and agreements by key market players fuels the market growth.

Key Players Covered

The report includes the profiles of key players such as Accuhealth Technologies LLC, Biofourmis, Connect America, Cardiomo, ChroniSense Medical, Ltd., HealthSaaS Inc., MayaMD., Somatix Inc., Feebris Ltd., Huma, Neteera Technologies Ltd., iHealth Labs Inc, Siemens Healthcare Private Limited, and HealthSnap, Inc.

Key Industry Developments

• In July 2023, Ambiq, a pioneer of ultra-low-power semiconductor solutions, launched the Apollo4 Lite and Apollo4 Blue Lite System-on-Chips (SoCs) to expand its portfolio of SoCs for IoT endpoint devices, especially the remote monitoring products across the healthcare sector.
• In July 2023, Hyfe Inc., a provider of AI-powered cough detection technology, launched its novel remote patient monitoring (RPM) program to provide an easy-to-use cough monitoring capability for virtual hospitals, remote care, and telehealth programs across the U.S.
• In October 2023, VitalConnect, a provider of wearable biosensor technology, entered into an agreement with Fifth Eye Inc., a provider of intuitive real-time clinical analytics, to provide predictive patient analytics that further advances remote monitoring.

In January 2022, OMRON Healthcare, Inc., a provider of medical equipment, launched its new remote patient monitoring services at the 2022 Consumer Electronics Show (CES).